Background: The capacity for total knee arthroplasty to improve pain, quality of life, and functional outcomes is widely
T he capacity for total knee arthroplasty (TKA) to improve pain, quality of life, and functional outcomes is widely recognized. Surgery also carries risks, including the risk of death. Reporting of 30-day mortality is preferred to reporting of in-hospital mortality because of differences in hospital discharge practices 1, 2 . Mortality up to 90 days is also widely reported. The rarity of mortality in the immediate postoperative period makes it difficult to investigate. However, risk of death is paramount to patients, their relatives, and health-care providers. The risk of postoperative death needs to be accurately quantified and conveyed to patients in order to inform decisions about treatment options. In addition, modifiable patient and surgical risk factors should be identified so that measures can be taken to address them. A study of data from 2003 to 2011 from the National Joint Registry for England and Wales showed a marked decline in mortality following TKA in England and Wales 3 . Therefore, we aimed to characterize trends in mortality after TKA and identify modifiable and nonmodifiable risk factors and the leading causes of death. We hypothesized that early postoperative mortality following TKA is falling globally. We used meta-regression to predict a contemporary estimate of 30 and 90-day mortality.
Materials and Methods
T he study outcomes of interest to this review were 30 and 90-day mortality following primary TKA. We excluded small studies in which no mortality was observed; studies presenting only in-hospital mortality and other time frames not of interest to this study; studies investigating mortality within specific subgroups of the overall population of those undergoing primary TKA (for example, simultaneous bilateral TKA, patients undergoing revision surgery, extremes of age, exclusively noncardiac patients); and studies in which hip and knee arthroplasty mortality data were combined and could not be separated. To prevent double counting, data sets that were presented in multiple publications were only included once. Numerous studies reported data from the American College of Surgeons National Surgical Quality Improvement Project (NSQIP) [4] [5] [6] [7] [8] [9] . To prevent double counting of NSQIP data within this review, 3 studies with overlapping data-collection periods were excluded from pooled statistical analyses. Unique secondary findings of these studies are, however, discussed in the narrative part of this review.
We used a rigorous systematic approach, as described in the Cochrane Handbook 10 and MOOSE (Meta-analysis Of Observational Studies in Epidemiology) guidelines 11 , for the conduct and reporting of this review. This review was registered on the PROSPERO database following preliminary searches (registration number CRD42016051100). August 16, 2016 , and included abstracts and studies published in any language. Using controlled vocabulary, we searched the terms "mortality," "knee," and "replacement or arthroplasty." Given the likely temporal association with mortality, and our aim to provide a contemporary estimate of mortality, searches were subsequently limited to studies published from 2006 to 2016. We also searched the reference lists of articles identified by this search strategy and included additional studies deemed relevant.
Search Strategy

Screening
A total of 731 records were identified from searching the literature; 2 experienced reviewers (J.R.B. and A.D.B.) independently screened the titles and abstracts of these records to identify potentially relevant articles for inclusion in this systematic review. After screening, 37 studies were included in this review.
Data Extraction and Risk-of-Bias Assessment
Data were extracted regarding the proportion of patients who had died at either 30 or 90 days postoperatively. Where adjusted or manipulated mortality data were reported, we contacted authors to request unadjusted rates, and those who responded and provided additional data are acknowledged. Study and participant characteristics were also recorded (cohort size, country of Forest plot of Poisson-normal random-effects model for studies reporting 30-day mortality, ordered by median year of study data collection.
study, median year of study data collection, mean age of patients, proportion of female patients, type of database used, inclusion and exclusion criteria, and risk-of-bias assessment). We also noted the causes of death, risk factors for mortality, and other adverse events. The characteristics of included studies are available in the Appendix. Risk of bias was assessed using relevant parts of the Newcastle-Ottawa Quality Assessment Scale: representativeness of the exposed cohort, ascertainment of exposure, assessment of outcome, and adequacy of follow-up of cohorts. Two authors (J.R.B. and A.D.B.) independently assessed risk of bias.
Statistical Analysis
We used the median year of data collection for each individual study for pooled analyses. Because of the rarity of mortality as an outcome after TKA, as well as heterogeneity in global health care, meta-analyses and meta-regressions were conducted using a Poisson-normal model with random effects. Logtransformed incidence rates were used as the effect measure. This approach has been shown to perform well in rare-event studies 12 . Effect estimates for individual and pooled studies are summarized in forest plots, and heterogeneity was assessed using the I 2 statistic to quantify inconsistency 13 . All statistical analyses were performed using the metafor package 14 within the R statistical environment 15 .
Subgroup Analysis and Investigation of Heterogeneity
We performed subgroup analyses to identify the sources of heterogeneity. Study size (<50,000, ‡50,000), median year of data collection (<2004, 2004 to 2006, 2007, >2007) , geographic origin (United States, Europe, rest of the world), and health insurance status (Medicare, other) were used to stratify the data in an attempt to identify sources of heterogeneity. Metaregressions were conducted with the median year of data collection as a variable.
Results
W
e included 37 studies of mortality after TKA from 15 different countries on 4 continents in which unadjusted 30 or 90-day mortality rates were recorded or made available by the authors [3] [4] [5] [6] [7] [8] [9] . Of these, 27 studies published from 2006 to 2016 reported 30-day mortality. Three of these studies were excluded because of overlapping data, and the remaining 24 were pooled. These included 1,753,449 TKAs performed from 1991 to 2014. The pooled 30-day Poisson-normal randomeffects estimate of mortality over the study period was 0.20% (95% confidence interval [CI], 0.17% to 0.24%) (Fig. 1) . The pooled 90-day estimate of mortality was 0.39% (95% CI, 0.32% to 0.49%), according to 17 studies published from 2006 to 2016 and including 700,981 TKAs performed from 1991 to 2014 (Fig. 2) . Forest plot of Poisson-normal random-effects model for studies reporting 90-day mortality, ordered by median year of study data collection.
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Three studies reported a temporal decline in mortality within their cohorts 3, 25, 40 . Using meta-regression, a significant temporal reduction in mortality was observed when the median year of surgery for each individual study was used as a moderator (p < 0.000005) (Fig. 3) . Log-transformed incidence rates were used with a Poisson-normal random-effects model to show that 30-day mortality following TKA in 2015 was 0.10% (95% CI, 0.07% to 0.14%). Heterogeneity fell from 95% to 88% with this model, suggesting that other sources of variation in mortality still exist. The trend for 90-day mortality was similar (p < 0.001). Meta-regression modeling showed that 90-day mortality following TKA in 2015 was 0.19% (95% CI, 0.15% to 0.23%) (Fig. 4) .
There were no significant differences in mortality between continents when meta-regressions included the geographic origin of the study as a moderator (p > 0.6). Controlling for the temporal trend toward declining mortality in meta-regressions further reduced the significance of any differences in mortality between continents (p > 0.9).
The period of increased mortality risk following TKA was described in 4 studies 3, 30, 35, 45 . Risk of mortality was highest in the first 10 days 30 and returned to preoperative baseline rates within 21 days 30 , 30 days 35, 45 , or 45 days 3 . Postoperative mortality was 5 times higher in the first 30 days compared with the same period prior to surgery, and when corresponding 90-day periods were analyzed, the postoperative mortality rate was double that of the equivalent preoperative period 35 . In a similar study, 30-day mortality for the age category of 61 to 70 years tripled postoperatively from baseline rates 30 . Cardiovascular causes, particularly myocardial infarction, were cited as the most common cause of death in studies in which the cause of death was reported 4, 28, 35, 38, 41 . Two studies with multivariate adjustment identified a prior cardiac event as a significant risk factor for postoperative 90-day mortality (odds ratio [OR], 3.0; 95% CI, 1.7 to 5.4) 40 and 45-day mortality (hazard ratio [HR], 3.46; 95% CI, 2.81 to 4.14) 3 . At later times, other unrelated causes of death became increasingly prevalent. For example, in a study of 90-day mortality, malignancy accounted for 14% of deaths 35 . Diabetes mellitus was identified as a medical comorbidity in 18.2% of patients undergoing TKA in a study by Belmont et al. from the United States. On multivariate logistic regression analysis, controlling for known risk factors for mortality, a diagnosis of diabetes was still associated with increased odds of mortality (OR, 2.99; 95% CI, 1.35 to 6.62) 4 . Seven studies reported increasing age as an independent risk factor for 30-day 5, 30, 31, 33, 45 and 90-day 36,40 mortality following TKA when controlling for comorbidities and other confounders.
Male sex appeared to be an important risk factor for mortality at 30 and 90 days compared with female sex (OR, 1.9 and 1.7, respectively; p < 0.001) in a multivariate analysis controlling for age and comorbidities in >200,000 TKAs 45 , confirmed by similar ORs in 3 other studies 30, 36, 40 . Fig. 3 Meta-regression bubble plot of 30-day mortality (with 95% CI) against median year of study data collection.
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Ethnicity did not appear to confer a difference in 30-day mortality 19, 45 ; however, at longer-term follow-up (60 to 180 days), lower mortality was observed in Asian patients on multivariate analysis 45 . Being mildly overweight appeared to confer a protective effect following TKA. Models adjusted for other comorbidities revealed the lowest mortality in the body mass index (BMI) category of 26 to 30 kg/m 2 (HR, 0.69; 95% CI, 0.54 to 0.88) when referenced to a normal BMI of 19 to 25 kg/m 23 . Smaller studies were not able to identify an association between mortality and BMI 4, 9 . Cerebrovascular disease, liver disease, and renal disease conferred significant HRs for mortality of 3.4, 7.2, and 2.2, respectively, in the study by Hunt et al. 3 . North America was represented in 21 studies; Europe, in 11; Asia, in 3; and Australia, in 2.
Overall, there was a low risk of bias in the studies included in this review; however, most studies were performed in a subset of the overall population undergoing TKA, for example, Medicare or National Health Service patients only. A summary of the risk-of-bias assessment is presented in Figure 5 .
Discussion
I
n this analysis, we identified a strong worldwide temporal decline in 30 and 90-day mortality following TKA. Although causality cannot be determined, a possible explanation for this decline may be related to improvements in health care over the past 20 years. For this trend toward decreasing mortality to continue, health-care providers will need to address the major cause of early postoperative mortality, identified as cardiovascular disease in our study.
Another possible explanation for declining mortality involves improving health and life expectancy of the population. The study by Hunt et al. showed that mortality following TKA fell at a faster rate than that expected when compared with the general population 3 . Although the results of our study may indicate improvements in population life expectancy, it appears that this Risk-of-bias summary. Meta-regression bubble plot of 90-day mortality (with 95% CI) against median year of study data collection. 20, 2018 may not fully explain the trends that we observe. Other studies comparing postoperative mortality with the general population are susceptible to underestimating the risk associated with surgery because of a selection bias toward operating on healthy patients. Variation in the reported mortality following TKA persisted despite controlling for the year of the study and was not explained by the continent on which the study was performed. This may be due to differences in the underlying populations or the delivery of health care. It is unlikely that differences in study design would account for the observed heterogeneity. All of the available studies reported on retrospective cohorts or retrospective analysis of prospectively collected data. Although the risk of bias was low in most studies, and it appeared that adequate processes were followed to ascertain the mortality status of patients at 30 and 90 days, there remains a greater potential for underreporting rather than overreporting mortality. This may have the effect of reducing the mortality estimates that we present.
The identification of modifiable risk factors is paramount to health-care providers, and efforts to address the risk from cardiovascular disease, diabetes, and extremes of BMI should be encouraged. The protective effect of being mildly overweight has been identified in studies of mortality in other disciplines and has been termed the obesity paradox 46, 47 . Age and male sex have also been confirmed as independent risk factors for mortality.
In summary, TKA is a safe procedure associated with low rates of mortality. A strong worldwide temporal trend toward declining mortality has emerged. Efforts to reduce cardiovascular and diabetes-related risks may reduce the mortality risk further.
